Investigations were undertaken to characterize the protective immunity induced by
porin-
lipopolysaccharide (LPS) against Salmonella typhimurium
infection in mice. Mice immunized with
porin-LPS showed higher levels of antiporin
immunoglobulin G than mice which received
porin alone. Further, T cells from
porin-LPS-immunized mice showed an augmented proliferative response to
porin in vitro compared with the response of T cells from
porin-injected animals. The passive transfer of anti-LPS
antibodies conferred significant protection (17%), while antiporin serum failed to protect mice against lethal challenge, indicating the protective ability of anti-LPS
antibodies. However, the transfer of serum obtained from
porin-LPS-immunized mice resulted in better protection (30%) than did anti-LPS or antiporin
antibodies alone. In contrast to LPS,
monophosphoryl lipid A completely failed to induce protection against lethal
infection. However, comparable to the effect of LPS, injection of
porin with
monophosphoryl lipid A enhanced antibody response and the protective ability of
porin (81.25%). The transfer of T cells from
porin-LPS-immunized mice provided higher levels of protection (47%) against lethal challenge than did T cells from
porin-immunized mice (23%). The combination of T cells and serum from
porin-immunized mice transferred 36% protection. However, a combination of T cells and serum from
porin-LPS-immunized mice conferred the highest level of protection (92%), which was reflected by the number of survivors (100%) in the
porin-LPS-immunized group. These results demonstrate that besides the protective effect of anti-LPS
antibodies, the ability of LPS to augment humoral and cell-mediated immune responses to
porin confers effective protection against
Salmonella infection.